Piperazine → HCID 13371673, compound
Reaction equation
Cl[C:2]1[N:11]=[C:10]([N:12]2[CH2:17][CH2:16][S:15](=[O:18])[CH2:14][CH2:13]2)[C:9]2[C:4](=[N:5][C:6]([N:20]3[CH2:25][CH2:24][O:23][CH2:22][CH2:21]3)=[C:7]([Cl:19])[N:8]=2)[N:3]=1.[NH:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1>>[Cl:19][C:7]1[N:8]=[C:9]2[C:4](=[N:5][C:6]=1[N:20]1[CH2:25][CH2:24][O:23][CH2:22][CH2:21]1)[N:3]=[C:2]([N:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1)[N:11]=[C:10]2[N:12]1[CH2:17][CH2:16][S:15](=[O:18])[CH2:14][CH2:13]1Participants
3
Procedure
This compound was prepared analogous to Example 1 from 2,6-dichloro-7-morpholino-4-(1-oxido-thiomorpholino)pteridine and piperazine.
Sources & evidence
- ORD record
- ord-9c2593079b614014a29687424b2a3292
- Source dataset
- uspto-grants-1985_12
- Patent number
- US04560685
Reaction notes
Loading…